Member Login

 
Forgot password/Login issues?
Not a Member? Learn more.
  • Blog
  • Partnership
  • Contact
  • Cart (0)
  • Member Login
BCC Research
BCC Research
  • Member Login
  • Solution
    • Membership Membership
      • Academic
      • Corporate
    • Market Research
    • Custom Research
    • Company Index
    • Scorecard
  • Industries Industries
    • Life Sciences Life Sciences
      • Med Devices & Surgical
      • Cell Biology
      • Pharmaceuticals
      • Health Maintenance
    • Digital World Digital World
      • Instrumentation & Sensors
      • Safety and Security
      • Engineering
      • Photonics
      • Information Technology
    • Materials Materials
      • Advanced Materials
      • Plastics
      • Chemicals
      • Semiconductor
      • Nanotechnology
    • Energy & Sustainability Energy & Sustainability
      • Water-Membrane and Separations
      • Fuel Cell and Battery
      • Food
      • Energy
      • Manufacturing
      • Environment
  • Resources Resources
    • Blog
    • e-Course
    • Spotlights Library
    • Megatrends
    • Association Exclusives
    • Partnership
    • Market Research Studies
  • About
    • About BCC Research
    • Press Releases
    • Events
    • Careers
    • Contact
  • Beacon SearchBeacon Search

Or Ask your question to the BCC Research BEACON Beacon Research

  1. Company Index
  2. Novartis AG
  3. News

Novartis AG

  • Overview
  • Financial
  • In Reports
  • Products
  • History
  • Point of Contacts
  • News

In News

Novartis wins approval for first malaria drug for newborns and babies - Reuters

Reuters - Jul 08, 2025

Novartis wins approval for first malaria drug for newborns - Financial Times

Financial Times - Jul 08, 2025

Novartis Wins Approval for First Malaria Medicine for Babies - Bloomberg

Bloomberg - Jul 08, 2025

Novartis gets approval of first malaria medicine for newborns - BioPharma Dive

BioPharma Dive - Jul 08, 2025

Novartis wins Swiss approval for Coartem Baby, first malaria drug for infants and young children - Seeking Alpha

Seeking Alpha - Jul 08, 2025

Novartis Gets Swiss Approval for Malaria Drug for Infants - MarketScreener

MarketScreener - Jul 08, 2025

Novartis Secures Approval For First Malaria Therapy for Babies - insights.citeline.com

insights.citeline.com - Jul 08, 2025

Novartis Gets Swiss Approval For First Malaria Drug For Babies - Novartis (NYSE:NVS) - Benzinga

Benzinga - Jul 08, 2025

Novartis AG (NVS) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Yahoo Finance - Jul 01, 2025

Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG - PR Newswire

PR Newswire - Apr 30, 2025

Deutsche Bank Reaffirms Their Buy Rating on Novartis AG (NOVN) - The Globe and Mail

The Globe and Mail - Jul 05, 2025

Novartis revenue 2014-2024 by segment - Statista

Statista - Jun 20, 2025

BCC Research Beacon
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Thank you for your interest in BCC Research. You will be added to our mailing list.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

Contact
  • 781-489-7301
  • info@bccresearch.com

© 2025 BCC Research

Privacy Policy |Site Map|Terms & Conditions

Please select categories of interest:

Check All